Now let me compile my final consolidated review.

## My Round-1 Bracket

The paper (HYPOGENEAGENT) sits between the weak anchors (ProtFunAgent avg 3.0, LangPert avg 3.0) and the middle anchors (CellAgent avg 4.0, SC-Arena avg 5.0, CellxPert avg 4.5, MARWA avg 4.5). Narrowest plausible range: **3.5 – 4.5**.

**Round 2 narrowing**: Compared against CellAgent (4.0, Accept Poster) — HYPOGENEAGENT has more specific conceptual novelty (resolution selection via annotation consistency) but weaker validation. Compared against CellxPert (4.5, Reject) — HYPOGENEAGENT has less architectural/empirical rigor. Compared against MARWA (4.5, Reject) — HYPOGENEAGENT's evaluation is less rigorous. The paper is closest in quality to CellAgent.

**Final calibrated score: 4.0**

## Review

## Summary
This paper proposes HYPOGENEAGENT, an LLM-agent framework that uses functional annotation consistency to select clustering resolution in Perturb-seq data. An LLM generates ranked GO hypotheses for each cluster; from these, Intra-Cluster Similarity (ICS) and Inter-Cluster Distinctiveness (ICD) are computed and combined into a Resolution Score. The score is maximized at a data-driven resolution (r=0.4 for GEX, r=0.5 for perturbation on K562 data), and the paper compares this against silhouette, modularity, and functional enrichment.

## Strengths

- **Novel integration of LLM-based annotation with resolution selection.** The idea of using LLM-generated GO hypothesis *consistency* (ICS and ICD) as a quantitative criterion for choosing clustering granularity is genuinely novel. Prior work used LLMs for post-hoc annotation only; this paper closes the loop between annotation and clustering hyperparameter selection. The formalization of ICS, ICD, and the Resolution Score (Section 3.4) is clean and principled.

- **Systematic Stage 1 benchmark for LLM/prompt/embedding selection.** The paper compares five LLMs (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro), three embedding methods, two prompt designs, and temperature ranges on 100 curated GOBP gene sets (Section 4.3, Stage 1). GPT-o3 with the hypothesis prompt is selected based on quantitative criteria (median cosine similarity to ground truth, AUC=0.743 at threshold 0.40). This provides a reproducible justification for the fixed configuration used downstream.

- **Formal definitions and dual-level application.** The paper defines clear metrics (ICS, ICD, Resolution Score) and applies them at both gene-expression and perturbation levels, with consistent results (r=0.4 GEX, r=0.5 perturbation). The convergence of both independent components (ICS and ICD) on the same resolution (Figures 3c,d and 4c,d) provides internal consistency evidence.

## Weaknesses

### Major

- **The central claim of "superior biological interpretability" is not quantitatively validated.** The paper argues that the Resolution Score selects biologically better clustering granularities than silhouette, modularity, or enrichment. However, there is no ground-truth benchmark for the "correct" resolution on this dataset (no known cell-type or perturbation-effect labels), and the quantitative support for superiority is absent. The functional enrichment analysis (Figure 6) — the closest thing to an external validator — produces a Resolution Score that peaks at r=0.7, *not* at the HYPOGENEAGENT-chosen r=0.4. The paper hand-waves: "consider the reasonability of cluster numbers we expected, so the selected resolution can be 0.5 or 0.4" (Section 4.4.3). This is a subjective backward-reasoning from expected cluster count, not a data-driven validation that the HYPOGENEAGENT choice is biologically better. The comparisons against silhouette (elbow at 0.5/0.6) and modularity (peak at 0.7) show that different metrics select different resolutions, but they do not demonstrate that r=0.4 yields *biologically more meaningful* partitions. A quantitative comparison — e.g., enrichment of known perturbation pathways at each resolution, or recovery of known marker genes — is needed to support the superiority claim.

- **The enrichment-based validation (Figure 6) does not support the paper's narrative.** The caption states "In (a), the resolution score peaks at 0.7." The paper then says the enrichment analysis validates the HYPOGENEAGENT choice because r=0.4 "can be" selected "consider[ing] the reasonability of cluster numbers." This is logically inconsistent — if the enrichment-based Resolution Score does not peak at the same resolution, it does not validate the HYPOGENEAGENT choice; it undermines it. At minimum, the paper should explain why the enrichment-based score selects a different optimum and what this discrepancy implies.

### Minor

- **"Calibrated confidence scores" is imprecise and potentially misleading.** The paper uses this term five times (abstract, Section 3.3, Figure 1, Sections 4.1, 4.3) but describes no calibration procedure (Platt scaling, isotonic regression, or similar). Figure S3 (in the appendix) shows that GPT-o3's self-assigned confidence correlates with semantic similarity to ground truth on the GOBP benchmark, which is evidence that the scores are *informative* but not that they are *calibrated* in the statistical sense. The paper should replace "calibrated" with "self-reported" or "raw" and either perform proper calibration or clarify the intended meaning.

- **The evidence retrieval tool is underspecified.** The method states only that the agent calls "a retrieval tool that surfaces concise functional summaries from GO, KEGG and PubMed" (Section 3.3). No details are given on which database/version is used, how many snippets are retrieved per gene, how they are filtered or ranked, or how they are integrated into the prompt. This limits reproducibility and makes it impossible to assess the quality of information the LLM receives.

- **"Orders of magnitude faster than manual curation" is unsubstantiated.** The conclusion makes this claim (Section 4.4, final paragraph) but provides no runtime, API cost, or wall-clock measurements. Given that GPT-o3 is called for every cluster at every resolution (up to 10 resolutions × ~20 clusters = 200 calls), reporting cost per run is necessary to support the claim and let readers assess practicality.

- **Number of clusters per resolution not reported in box plots.** Some resolutions yield very few clusters (e.g., r=0.1 may produce 1–2 clusters), making the box plots unreliable at the extremes. Reporting the cluster count per resolution would help the reader interpret the variability shown in Figures 3 and 4.

### Trivial

None.

## Nice-to-Haves

- A sensitivity analysis of the optimal resolution to the weight parameter w (Figure S5 apparently exists in the appendix; it would strengthen the paper to show this analysis or its key findings in the main text).
- Side-by-side biological quality comparison at each resolution (e.g., average pairwise pathway enrichment overlap, or recovery of known marker genes) to quantitatively compare HYPOGENEAGENT-chosen resolutions against silhouette/modularity optima.

## Removed Points

- **"Stage 1 benchmark uses cosine similarity which is not a measure of biological accuracy"** — The paper uses this as a configuration-selection tool (which LLM/prompt to use), not as a measure of downstream biological validity. This is a reasonable use of the metric for the stated purpose.
- **"The grid search for w=1/3 is not detailed"** — The paper states it was "chosen by a small grid search and found to give a stable ordering of resolutions across data sets" and Figure S5 tests w in [0,1], partially addressing this.
- **"Missing related works"** — Cannot be confirmed without external sources; the paper's related work section is reasonably comprehensive.
- **"Prompt templates not in main text"** — The paper refers to the appendix (standard in many venues) for full prompts.
- **Strength: "enrichment analysis whose own agent-derived Resolution Score also peaks at 0.5/0.4 (Figure 6a)"** — This is factually incorrect; Figure 6a caption states the score peaks at 0.7. Removed.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
1. **Add quantitative biological validation.** The paper needs at least one of: (a) a held-out set of known perturbation targets with enrichment statistics at each resolution, (b) application to a dataset with ground-truth cell-type/perturbation labels, or (c) a comparison across multiple datasets showing that the Resolution Score optimum corresponds to the best value of an independent biological quality metric (e.g., recovery of known marker genes).
2. **Remove or qualify the enrichment-based validation claim** (Figure 6) since the enrichment Resolution Score peaks at 0.7, not 0.4. Either explain the discrepancy or present the enrichment analysis as complementary rather than confirmatory.
3. **Replace "calibrated confidence scores" with "self-reported confidence scores"** or add a calibration procedure.
4. **Provide runtime and cost estimates** for the full resolution sweep to support the efficiency claim.
5. **Specify the retrieval tool** (database versions, snippet count, filtering criteria) in the main text.

## Score and Decision

**Anchors used for calibration:**
- *KjyQhJUobQ* (ProtFunAgent, avg 3.00, Round 1, weak anchor): Protein function prediction with LLM agent + GO constraints. HYPOGENEAGENT is stronger — more specific contribution and cleaner formulation, but similar validation limitations. **→ Paper is above this anchor.**
- *ybmX4yvtGK* (LLM-BMC, avg 3.00, Round 1, weak anchor): Bayesian classification with LLM knowledge. Less relevant topic but similar score tier. **→ Paper is above this anchor.**
- *GJnatqABL8* (scLDM, avg 3.33, Round 1, weak anchor): Single-cell generative model. HYPOGENEAGENT has a clearer evaluation pipeline and more novel contribution. **→ Paper is above this anchor.**
- *uTderO7iyk* (LangPert, avg 3.00, Round 1, weak anchor): LLM-guided perturbation prediction. Similar domain, LangPert has more limited evaluation. **→ Paper is above this anchor.**
- *BsA2GNkJhz* (CellAgent, avg 4.00, Rounds 1 & 2, middle anchor): LLM multi-agent for single-cell analysis. Most comparable: both novel integrations of LLMs with single-cell pipelines, both have validation concerns. CellAgent has broader evaluation across 60+ datasets; HYPOGENEAGENT has more focused conceptual novelty. **→ Paper is comparable to this anchor.**
- *5RcoUe1tA1* (SC-Arena, avg 5.00, Rounds 1 & 2, middle anchor): Benchmark for LLMs in single-cell. More rigorous evaluation design and broader scope. **→ Paper is below this anchor.**
- *gfamCTnXMg* (CellxPert, avg 4.50, Rounds 1 & 2, middle anchor): Multimodal single-cell foundation model. Stronger evaluation benchmarks but similar validation concerns led to rejection. **→ Paper is slightly below this anchor.**
- *uA8BcIuZc4* (scREBOUND, avg 4.67, Round 1, middle anchor): Single-cell foundation model. Stronger overall engineering contribution. **→ Paper is below this anchor.**
- *EcbUaXJb9s* (MARWA, avg 4.50, Round 2, middle anchor): Multi-agent bioinformatics workflow. More rigorous two-stage evaluation. **→ Paper is below this anchor.**
- *9gw03JpKK4* (Gaia2, avg 8.00, Round 1, high anchor): LLM agent benchmark. Not comparable in quality. **→ Paper is far below this anchor.**

**Final score rationale**: The paper has a genuinely novel idea (using LLM annotation consistency for clustering resolution selection) and a well-structured pipeline. However, the central claim of superior biological interpretability is not quantitatively validated — the enrichment analysis intended as validation actually peaks at a different resolution, and no ground-truth benchmark is provided. Combined with imprecise terminology ("calibrated") and underspecified implementation details, the paper sits at a 4.0, comparable to CellAgent (4.0, Accept Poster) — a paper with similar levels of novelty offset by validation gaps.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>